Antimicrobial stewardship strategies for implementing the 2019 EUCAST “I” definition
Open Access
- 6 December 2025
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
In 2019, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) redefined the “I” category from “intermediate susceptibiKeywords
All Related Versions
This publication has 25 references indexed in Scilit:
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050The Lancet, 2024
- EUCAST breakpoint categories and the revised “I”: a stewardship opportunity for “I”mproving outcomesClinical Microbiology and Infection, 2022
- Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospitalClinical Microbiology and Infection, 2022
- The effectiveness of Check of Medication Appropriateness for antimicrobial stewardship: an interrupted time series analysisJournal of Antimicrobial Chemotherapy, 2021
- Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibilityClinical Microbiology and Infection, 2020
- In the name of common sense: EUCAST breakpoints and potential pitfallsClinical Microbiology and Infection, 2020
- New EUCAST definitions of S, I and R from 2019 – German physicians are largely not aware of the changesInfection, 2020
- The role of electronic health record and “add-on” clinical decision support systems to enhance antimicrobial stewardship programsInfection Control & Hospital Epidemiology, 2019
- EUCAST proposes to change the definition and usefulness of the susceptibility category ‘Intermediate’Clinical Microbiology and Infection, 2017
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002